DM
CRBU icon

Deerfield Management’s Caribou Biosciences CRBU Stock Holding History

Deerfield Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,500,000
Closed -$16.7M – 225
2023
Q3 		$16.7M Buy
+3,500,000
New +$21.7M 0.37% 47

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Deerfield Management's CRBU Position: Q4 2023 in Review

Deerfield Management sold out of Caribou Biosciences (CRBU) in Q4 2023, closing a stake of 3,500,000 shares — an estimated $16.7M sold.

Deerfield Management first reported a position in CRBU in Q3 2023 and held it in 1 quarter. The position peaked at $16.7M in Q3 2023. 144 funds tracked by Wall St. Rank hold CRBU as of Q4 2023.

  • Deerfield Management reported no remaining Caribou Biosciences position as of Q4 2023 after selling out during the quarter.
  • Deerfield Management sold 3,500,000 Caribou Biosciences shares in Q4 2023, an estimated $16.7M.
  • Deerfield Management first reported a position in Caribou Biosciences in Q3 2023 and held it in 1 quarter.
  • Deerfield Management's Caribou Biosciences position peaked at $16.7M in Q3 2023.
  • 144 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2023.

Based on Deerfield Management's 13F filing for Q4 2023, filed 14 Feb 2024.